FDA.reportPublic FDA data

Nadinola Skin Fade Cream for Dry Skin

Manufacturer
J. Strickland & Co.
Effective date
2018-01-19
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:04:43

Label at a glance#

ProductNadinola Skin Fade for Dry Skin
Active ingredientHYDROQUINONE, OCTISALATE
Label structure6 sections

Indications and uses

Gradually fades areas of skin discoloration such as age spots  freckles  liver spots  dark areas that can occur while using oral contraceptives.

Dosage and administration

If skin is sensitive, test on a small area inside elbow overnight before use.  Adults and children 12 years and older, apply as a thin layer toaffected area twice daily, or as directed by a doctor. If going outside, use a sunscreen or wear protective clothong.  Children under 12 years of age, ask a doctor before use.

Label contents#

Full prescribing information#

Active Ingredients:

OTC - ACTIVE INGREDIENT SECTION

Hydroquinone, 2%, Octisalate, 3%

Purpose

OTC - PURPOSE SECTION

Skin Lightener

Sunscreen

Uses:

INDICATIONS & USAGE SECTION

Gradually fades areas of skin discoloration such as

  • age spots 
  • freckles 
  • liver spots 
  • dark areas that can occur while using oral contraceptives.

Warnings:

WARNINGS SECTION

For External Use Only.

Do not use

OTC - DO NOT USE SECTION

  • on inflamed or brocken skin 
  • to prevent sunburn  
  • if product is tan or brown

When using this product

OTC - WHEN USING SECTION

  • mild irration may occur 
  • avoid contact with eyes. If contact occurs, Rinse With water.
  • avoid unnecessary sun exposure and use a sunscreen or protective clothing

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • a gradual blue black darkening of the skin occurs 
  • irritation is severe 
  • no improvement is seen after 3 months

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

consult a health professional before use

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Directions:

DOSAGE & ADMINISTRATION SECTION

  • If skin is sensitive, test on a small area inside elbow overnight before use. 
  • Adults and children 12 years and older, apply as a thin layer toaffected area twice daily, or as directed by a doctor.
  • If going outside, use a sunscreen or wear protective clothong. 
  • Children under 12 years of age, ask a doctor before use.

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

water, glyceryl stearate, isopropyl myristate, PEG-8, cetyl alcohol, PEG-100 stearate, fragrance, citric acid, methylparaben, propylparaben, sodium bisulfite.

Package Labeling

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

12022-012-0012022-012-00

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
12022-01212022-012-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
GLYCERYL MONOSTEARATE230OU9XXE4IACT
ISOPROPYL MYRISTATE0RE8K4LNJSIACT
POLYETHYLENE GLYCOL 400B697894SGQIACT
CETYL ALCOHOL936JST6JCNIACT
PEG-100 STEARATEYD01N1999RIACT
CITRIC ACID MONOHYDRATE2968PHW8QPIACT
METHYLPARABENA2I8C7HI9TIACT
PROPYLPARABENZ8IX2SC1OHIACT
SODIUM BISULFITETZX5469Z6IIACT
HYDROQUINONEXV74C1N1AEACTIB
OCTISALATE4X49Y0596WACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b34c1765-d7b3-0c8c-e053-2a95a90a6b2106829ae5-9ba1-4dee-ba08-56c756f7b9782020-11-04WarningsExact identifier
spl set id: 06829ae5-9ba1-4dee-ba08-56c756f7b978

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.